Engineered upconversion nanocarriers for synergistic breast cancer imaging and therapy: Current state of art

J Control Release. 2022 Dec:352:652-672. doi: 10.1016/j.jconrel.2022.10.056. Epub 2022 Nov 8.

Abstract

Breast cancer is the most common type of cancer in women and is the second leading cause of cancer-related deaths worldwide. Early diagnosis and effective therapeutic interventions are critical determinants that can improve survival and quality of life in breast cancer patients. Nanotheranostics are emerging interventions that offer the dual benefit of in vivo diagnosis and therapeutics through a single nano-sized carrier. Rare earth metal-doped upconversion nanoparticles (UCNPs) with their ability to convert near-infrared light to visible light or UV light in vivo settings have gained special attraction due to their unique luminescence and tumor-targeting properties. In this review, we have discussed applications of UCNPs in drug and gene delivery, photothermal therapy (PTT), photodynamic therapy (PDT) and tumor targeting in breast cancer. Further, present challenges and future opportunities for UCNPs in breast cancer treatment have also been mentioned.

Keywords: Bioimaging; Breast cancer; Drug delivery; Photodynamic therapy; Photothermal therapy; Upconversion nanoparticles.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms* / diagnostic imaging
  • Breast Neoplasms* / therapy
  • Female
  • Humans
  • Infrared Rays
  • Nanoparticles* / therapeutic use
  • Photochemotherapy*
  • Quality of Life